© The American Society of Gene & Cell Therapy original article Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-l-Iduronidase in Mice With

[1]  A. Schambach,et al.  A Self-inactivating γ-Retroviral Vector Reduces Manifestations of Mucopolysaccharidosis I in Mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  J. Tolar,et al.  Gender-related dimorphism in aortic insufficiency in murine mucopolysaccharidosis type I. , 2009, The Journal of heart valve disease.

[3]  J. Parker,et al.  Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  J. Wolff,et al.  Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery. , 2009, Human gene therapy.

[5]  Dexi Liu,et al.  Image-guided, lobe-specific hydrodynamic gene delivery to swine liver. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  J. Tolar,et al.  α-L-iduronidase therapy for mucopolysaccharidosis type I , 2008, Biologics : targets & therapy.

[7]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[8]  G. Freeman,et al.  Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice. , 2008, Blood.

[9]  K. Ponder,et al.  Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice , 2008, The journal of gene medicine.

[10]  M. Mcentee,et al.  Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I. , 2008, The Journal of clinical investigation.

[11]  S. E. Barker,et al.  Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis , 2008, Gene Therapy.

[12]  M. Kay,et al.  Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  D. Jaeck,et al.  Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human , 2008, Cancer Gene Therapy.

[14]  A. Annoni,et al.  A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. , 2007, Blood.

[15]  Luigi Naldini,et al.  Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state , 2007, Nature Biotechnology.

[16]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[17]  L. Belur,et al.  Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidoses , 2007, The journal of gene medicine.

[18]  K. Ponder,et al.  Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  K. Ponder,et al.  Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice. , 2007, Molecular genetics and metabolism.

[20]  L. Naldini,et al.  Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy. , 2006, Human gene therapy.

[21]  Bin Wang,et al.  Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  L. Naldini,et al.  Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer , 2006, Nature Medicine.

[23]  S. Ekker,et al.  Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. , 2005, Human gene therapy.

[24]  J. Calvete,et al.  Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles , 2005, Gene Therapy.

[25]  M. Kay,et al.  Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. , 2005, Human gene therapy.

[26]  A. Rudensky,et al.  Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). , 2005, Blood.

[27]  M. Kay,et al.  Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. , 2005, Human gene therapy.

[28]  L. Naldini,et al.  Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector. , 2005, Human gene therapy.

[29]  Seng H. Cheng,et al.  Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy , 2004, Expert opinion on drug delivery.

[30]  I. Tsvetkova,et al.  The Phenotypic Characters of the Stem Cells in Hepatocytes during Liver Regeneration: The Expression of the Bcrp1/Abcg2 Membrane Transporter and the Hoechst 33342 Export , 2004, Doklady Biological Sciences.

[31]  M. Kay,et al.  Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo , 2004, Gene Therapy.

[32]  M. Kay,et al.  Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[34]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[35]  B. Brown,et al.  Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy. , 2002, Blood.

[36]  C. Walsh,et al.  Induction of tolerance to human factor VIII in mice. , 2001, Blood.

[37]  M. Kay,et al.  Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[38]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[39]  G. Freeman,et al.  ICOS is critical for CD40-mediated antibody class switching , 2001, Nature.

[40]  J. Wolff,et al.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. , 1999, Human gene therapy.

[41]  F. Jirik,et al.  Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene. , 1997, Human molecular genetics.

[42]  D. Sleat,et al.  Ligand Binding Specificities of the Two Mannose 6-Phosphate Receptors* , 1997, The Journal of Biological Chemistry.

[43]  J. Wraith,et al.  The presenting features of mucopolysaccharidosis type IH (Hurler syndrome) , 1995, Acta paediatrica.

[44]  Luigi Naldini,et al.  Stable knockdown of microRNA in vivo by lentiviral vectors , 2009, Nature Methods.

[45]  J. Tolar,et al.  Targeting of the CNS in MPS-IH Using a Nonviral Transferrin-α-l-iduronidase Fusion Gene Product. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  D. W. Emery,et al.  The cHS4 chromatin insulator reduces gammaretroviral vector silencing by epigenetic modifications of integrated provirus , 2008, Gene Therapy.